RussellDCohenMDAGAF, FACG
Gastroenterology • Chicago, ILInflammatory Bowel Disease
Professor of Medicine, University of Chicago Medicine
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 773-702-2182
Education & Training
University of ChicagoFellowship, Gastroenterology, 1993 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
Icahn School of Medicine at Mount SinaiClass of 1990- University of Chicago Medical CenterFellowship, Health Studies
University of ChicagoFellowship, Inflammatory Bowel Disease
Cornell UniversityBS, Biological Sciences
Certifications & Licensure
IL State Medical License 1993 - 2026
IN State Medical License 2023 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellows (FACG) The American College of Gastroenterology, 2004
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 31 citationsDifferential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease.Jacob E. Ollech, Maya Aharoni-Golan, Roni Weisshof, Inessa Normatov, Abby R. Sapp
Gastrointestinal Endoscopy. 2019-08-01 - 28 citationsUpadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.Scott Friedberg, David Choi, Thomas Hunold, Natalie K Choi, Nicole M Garcia
Clinical Gastroenterology and Hepatology. 2023-07-01 - 101 citationsOpen-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.Waqqas Afif, Jonathan A. Leighton, Stephen B. Hanauer, Edward V. Loftus, William A. Faubion
Inflammatory Bowel Diseases. 2009-09-01
Journal Articles
- Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective StudySushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences
- Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive ReportRussell D Cohen, Uma Mahadevan, Bruce A Salzberg, Gary R Lichtenstein, William J Sandborn, Michael Safdi, Nature
Authored Content
- Effectiveness of Ustekinumab Dose Escalation in Crohn's PatientsFebruary 2020
- Assessment of Peri-Polyp Biopsy Specimens of Flat Mucosa in Patients with Inflammatory Bowel DiseaseApril 2018
- Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients with Inflammatory Bowel DiseaseJanuary 2018
Press Mentions
New Guidelines Recommend Stool and Blood Tests to Monitor Ulcerative ColitisFebruary 24th, 2023- 203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
VIDEO: Entyvio Post-Marketing Safety Data Consistent with Previous Clinical TrialsDecember 17th, 2018- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
